Amplitude Ventures

The company was created by Amplitude Ventures, which also led the seed round alongside The Hospital for Sick Children, Amplitude's launch partner.

Versant Ventures and Amplitude Ventures led the Series A round, while venBio Partners led the Series B round.

The C$100 million Thrive Lab will be launched officially in the spring of 2023.

Canadian venture capital firm Amplitude Venture Capital closed its debut precision medicine fund, securing its C$200 million target.

Amplitude Venture Capital raised more than C$50 million in the second close of its debut precision medicine fund, bringing it to more than 75 percent of its C$200 million target.

Amplitude Venture Capital has launched a $200 million fund. So far, the fund has raised 50 percent of its target. The fund will invest in Canadian healthcare companies. Amplitude was co-created with cornerstone investor BDC Capital.

The BDC spin-out has raised over half of the C$200 ($152 million) target for its first fund.

PetalMD Solutions has acquired Xacte, a Québec City-based company specializing in web solutions for medical billing. No financial terms were disclosed. The deal was backed by the Growth and Transition Capital division of BDC Capital as part of its investment in PetalMD's Canadian and European growth strategy. PetalMD, a Québec City-based provider of web and mobile productivity tools to healthcare professionals, said the Xacte buy will add more value to its products. Founded in 2009 by CEO Patrice Gilbert, the company currently serves more than 37,000 physician users in over 150 healthcare institutions and 1,400 hospital departments.

We spoke to a dozen LPs for our cover story. They are upbeat about VC and, despite a lack of distributions, appear keen on supporting venture managers or pursuing new ones.

Limited partners include the government of Canada, which invested through BDC Capital, Canada Pension Plan Investment Board (CPP Investments), as well as high-net-worth individuals and family offices.

The Canadian early-stage investor plans to invest larger amounts in more kinds of fintech start-ups with its larger sophomore fund.

Based in Quebec City, LeddarTech is an automotive software company that provides low-level sensor fusion and perception technology.

ChrysaLabs is a Montreal-based agriculture technology startup providing portable, accurate and real-time soil data solutions.

Recursion agreed to buy Toronto-based Cyclica for $40 million and Montreal-based Valence for $47.5 million.

Edmonton-based DrugBank, a provider of structured drug data solutions, has collected C$9 million in seed financing.

Montreal-based biotechnology startup Congruence Therapeutics has secured $50 million in Series A financing.